永福股份(300712.SZ):寧德時代累計減持143.97萬股
格隆匯2月14日丨永福股份(300712.SZ)公佈,收到股東寧德時代新能源科技股份有限公司(簡稱“寧德時代”)出具的《關於權益變動的告知函》,獲悉寧德時代於2025年1月14日至2025年2月14日期間通過集中競價交易方式累計減持公司股份1,439,700股;同時,2022年6月10日至2023年7月26日期間,因公司進行第一期限制性股票激勵計劃歸屬股份登記,公司總股本由182,104,000股增加至187,546,035股,導致寧德時代持股比例被動稀釋。前述因素綜合導致寧德時代持股比例由7.9998%變動至7.0000%,觸及1%的整數倍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.